57 results
Page 3 of 3
8-K
EX-99.1
zidh1pwm2pdsyyvfaro
13 Aug 21
Longeveron Announces Topline Results of Phase 2b Study of Lomecel-B for Aging Frailty
1:46pm
10-Q
tuor0uy 5uh7r05417
14 May 21
Quarterly report
4:08pm
8-K
EX-99.1
nv2kn
11 May 21
Regulation FD Disclosure
11:42am
8-K
EX-99.1
pevbdu z1buwm1bat
15 Apr 21
Regulation FD Disclosure
9:08am
10-K
bbd x488r
30 Mar 21
Annual report
4:51pm
10-K
EX-1.1
pv6i3dsopjnqwjtseu
30 Mar 21
Annual report
4:51pm
424B4
zt51 fpiksld
12 Feb 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-1.1
7knx lxls
3 Feb 21
IPO registration (amended)
4:57pm
S-1/A
1mqc9x1
3 Feb 21
IPO registration (amended)
4:57pm
S-1/A
EX-10.13
mll2mgs
3 Feb 21
IPO registration (amended)
4:57pm
S-1
l6cw4tmd5mezp
19 Jan 21
IPO registration
5:21pm
S-1
EX-10.4
xnrqe5 px48
19 Jan 21
IPO registration
5:21pm
DRS/A
gx4 b3d6nrm6at
30 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.4
l7z804
30 Dec 20
Draft registration statement (amended)
12:00am
DRS
bnn e7smdirtwc
12 Nov 20
Draft registration statement
12:00am